Faheem Hasnain - 04 Mar 2025 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
President & CEO, Director
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol
GOSS
Transactions as of
04 Mar 2025
Transactions value $
$0
Form type
4
Filing time
06 Mar 2025, 16:03:10 UTC
Previous filing
24 Jun 2024
Next filing
24 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOSS Stock Option (Right to Buy) Award $0 +1.54M $0.00 1.54M 04 Mar 2025 Common Stock 1.54M $1.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total number of shares subject to the option will vest on March 4, 2026 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.